Arkana Advances

Arkana Advances

By Arkana LaboratoriesMedicine
Download on the App Store

Arkana Advances episodes

  • Infantile Nephrocalcinosis Resulting From A Pathogenic CYP24A1 Mutation
    Nephrocalcinosis is the finding of abundant calcium phosphate deposits within the tubulointerstitium of the kidney. This is a case report of a renal biopsy from an 11 month old male with hypercalcemia and developmental delay, who was found to have nephrocalcinosis. It is a rare diagnosis in infants, and should prompt a genetic workup. Genetic workup revealed a CYP24A1 mutation, which results in a truncated protein. This is a novel mutation in this gene. CYP24A1 is involved in Vitamin D metabolism. It is important to publish these mutations so geneticists can create databases of pathogenic mutations, and to provide prognostic information to patients.
     
    Read the Paper: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551537/pdf/main.pdf
     
    Watch the episode: https://www.youtube.com/watch?v=lxQrEIbbb0E
    11 min
  • Resistant Starch Slows the Progression of CKD in the 5/6 Nephrectomy Mouse Model
    In patients with chronic kidney disease, toxins normally excreted by the kidney continue to circulate, leading to increased kidney damage. The gut microbiome likely plays a role in this damage and contributes to systemic inflammation. Supplementation with dietary fiber (resistant starch) may prevent this kidney damage. This study uses a mouse model of chronic kidney disease and showed that mice fed resistant starch had significantly less kidney fibrosis. A diet including resistant starch altered the gut microbiome, with changes detected in proteins involved in gut permeability and the inflammatory response. This dietary change may improve outcomes in patients living with chronic kidney disease.
    Read the paper: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547583/pdf/PHY2-8-e14610.pdf
    [embed]https://youtu.be/QGY_mcILcIQ[/embed]
    12 min
  • A Diagnostician’s Field Guide To Crystalline Nephropathies
    This discussion focuses on a review article of crystals seen in renal biopsies. Crystalline nephropathies are often associated with systemic conditions. We discuss calcium-based crystals, dysproteinemia-related (such as light chain), crystal storing histiocytosis, crystalglobulin/cryocrystalglobulin, metabolic disorders, and drug-associated crystals. We review the appearance of the crystals, their etiology, and the associated prognosis for the patient. This is an excellent synopsis of the most common renal crystals for both trainees and practicing renal pathologists.
    Read the Paper: A diagnostician's field guide to crystalline nephropathies
    [embed]https://youtu.be/KpDPpzHLiZI[/embed]
    20 min
  • A Practical Approach To The Pathology Of Renal Intratubular Casts
    Dr. May discusses a review article with Dr. Dvanajsack that focuses on renal intratubular casts in Episode 5 of Arkana Advances.
    Both benign casts as well as six types of pathologic casts are addressed (light chain casts, myoglobin/hemoglobin casts, red blood cell casts, neutrophil casts, and bile casts). The pair review the appearance of these casts, their etiology, and the associated prognosis for the patient. This is an excellent synopsis of the most common renal casts for both trainees and practicing renal pathologists.
    Read the paper: A Practical Approach To The Pathology Of Renal Intratubular Casts
    [embed]https://youtu.be/EOYSCkSjBYg[/embed]
    22 min
  • Viral-like Inclusions in COVID-19 Negative Renal Biopsies by Electron Microscopy
    In Episode 4 of Arkana Advances, Dr. May interviews Dr. Cassol over her recent publication discussing viral-like inclusions in COVID-19 negative renal biopsies detected by electron microscopy.
    Early in the COVID-19 pandemic in the United States, few publications from different organ systems claimed to have found COVID-19 viral particles, including in the kidney. Viral particles are known to be of varying sizes, making proper identification even more difficult. To see whether these viral particles are specific for COVID-19 infection, both pre-COVID and COVID-era biopsies were examined. Viral-like inclusions were seen in all cases studied. These mimickers of COVID virions are hypothesized to be clathrin-coated endocytic vesicles, microvesicular bodies, or small organelles. COVID-19 ISH was performed in a few cases of patients with active COVID, and no viral RNA was detected. The CDC has outlined principles of identification of viruses on electron microscopy, including the proper protocols for preparation of the samples.
    Read the Paper: Viral-like Inclusions in COVID-19 Negative Renal Biopsies by Electron Microscopy
    [embed]https://youtu.be/45-ZHL1gVSc[/embed]
    15 min
  • Viral-like Inclusions in COVID-19 Negative Renal Biopsies by Electron Microscopy
    In Episode 4 of Arkana Advances, Dr. May interviews Dr. Cassol over her recent publication discussing viral-like inclusions in COVID-19 negative renal biopsies detected by electron microscopy.
    Early in the COVID-19 pandemic in the United States, few publications from different organ systems claimed to have found COVID-19 viral particles, including in the kidney. Viral particles are known to be of varying sizes, making proper identification even more difficult. To see whether these viral particles are specific for COVID-19 infection, both pre-COVID and COVID-era biopsies were examined. Viral-like inclusions were seen in all cases studied. These mimickers of COVID virions are hypothesized to be clathrin-coated endocytic vesicles, microvesicular bodies, or small organelles. COVID-19 ISH was performed in a few cases of patients with active COVID, and no viral RNA was detected. The CDC has outlined principles of identification of viruses on electron microscopy, including the proper protocols for preparation of the samples.
    Read the Paper: Viral-like Inclusions in COVID-19 Negative Renal Biopsies by Electron Microscopy
    Watch the Episode: https://youtu.be/45-ZHL1gVSc
    15 min
  • Collapsing Glomerulopathy and APOL1 High-Risk Genotype Associated with Covid-19
    Dr. May and Dr. Larsen discuss Covid-19 and its effect on collapsing glomerulopathy and APOL1 in Episode 3 of Arkana Advances.
    Collapsing glomerulopathy is a variant of focal segmental glomerulosclerosis (FSGS) in which there is capillary loop collapse and epithelial cell hyperplasia and hypertrophy. There is rapid progression to end-stage renal disease. Early in the COVID-19 pandemic in the United States, these publications demonstrated for the first time that collapsing glomerulopathy is seen in African American patients with COVID-19 infection, and is associated with an APOL1 High-Risk genotype. Direct viral infection of the kidney parenchyma was not identified. NanoString analysis showed activation of genes involved in tubular injury, as well as chemokines/cytokines and immunoglobulin.  These findings are similar to that seen in HIV-associated nephropathy, wherein patients with an APOL1 high-risk genotype, HIV serves as a "second hit" to initiate collapsing glomerulopathy. Multiple publications have since confirmed, on a larger scale, the association of COVID-19 and collapsing glomerulopathy.
    Read the papers: Collapsing Glomerulopathy in a patient with COVID-19 and AKI and Collapsing Glomerulopathy Associated with COVID-19 and APOL1 High-Risk Genotype
    [embed]https://youtu.be/mWyAepgQDCI[/embed]
    16 min
  • Collapsing Glomerulopathy and APOL1 High-Risk Genotype Associated with Covid-19
    Dr. May and Dr. Larsen discuss Covid-19 and its effect on collapsing glomerulopathy and APOL1 in Episode 3 of Arkana Advances.
    Collapsing glomerulopathy is a variant of focal segmental glomerulosclerosis (FSGS) in which there is capillary loop collapse and epithelial cell hyperplasia and hypertrophy. There is rapid progression to end-stage renal disease. Early in the COVID-19 pandemic in the United States, these publications demonstrated for the first time that collapsing glomerulopathy is seen in African American patients with COVID-19 infection, and is associated with an APOL1 High-Risk genotype. Direct viral infection of the kidney parenchyma was not identified. NanoString analysis showed activation of genes involved in tubular injury, as well as chemokines/cytokines and immunoglobulin.  These findings are similar to that seen in HIV-associated nephropathy, wherein patients with an APOL1 high-risk genotype, HIV serves as a "second hit" to initiate collapsing glomerulopathy. Multiple publications have since confirmed, on a larger scale, the association of COVID-19 and collapsing glomerulopathy.
    Read the papers: Collapsing Glomerulopathy in a patient with COVID-19 and AKI and Collapsing Glomerulopathy Associated with COVID-19 and APOL1 High-Risk Genotype
    Watch the video: https://youtu.be/mWyAepgQDCI
    16 min
  • Anti-Brush Border Antibody Disease (Anti-LRP2 Nephropathy) Associated with Lupus Nephritis
    Anti-brush border antibody disease is a rare autoimmune disease. Auto-antibodies are targeted against LRP2/Megalin, which is present on the apical brush border of the proximal tubule epithelial cells and is an endocytic receptor for many substances. This disease is typically seen in elderly patients who present with acute kidney injury. On renal biopsy, light microscopy shows acute tubular injury. Granular tubular basement membrane, as well as apical brush border staining for IgG, is seen on immunofluorescence. IgG and LRP2 colocalize along the tubular basement membrane. In this case report, a 55-year-old male with a recent diagnosis of Lupus underwent kidney biopsy for acute kidney injury and proteinuria. He was found to have focal lupus nephritis, class III, as well as anti-brush border antibody disease. Serology for LRP2 antibodies was positive. This is the first case report of this disease in a patient with lupus and is unusual in that the patient is non-elderly. This may be an under-recognized disease, especially in patients with other autoimmune diseases.\
    Read the publication: Anti–Brush Border Antibody Disease (Anti-LRP2 Nephropathy) Associated With Lupus Nephritis
    [embed]https://youtu.be/VBiBBeJHJc4[/embed]
    12 min
  • Anti-Brush Border Antibody Disease (Anti-LRP2 Nephropathy) Associated with Lupus Nephritis
    Anti-brush border antibody disease is a rare autoimmune disease. Auto-antibodies are targeted against LRP2/Megalin, which is present on the apical brush border of the proximal tubule epithelial cells and is an endocytic receptor for many substances. This disease is typically seen in elderly patients who present with acute kidney injury. On renal biopsy, light microscopy shows acute tubular injury. Granular tubular basement membrane, as well as apical brush border staining for IgG, is seen on immunofluorescence. IgG and LRP2 colocalize along the tubular basement membrane. In this case report, a 55-year-old male with a recent diagnosis of Lupus underwent kidney biopsy for acute kidney injury and proteinuria. He was found to have focal lupus nephritis, class III, as well as anti-brush border antibody disease. Serology for LRP2 antibodies was positive. This is the first case report of this disease in a patient with lupus and is unusual in that the patient is non-elderly. This may be an under-recognized disease, especially in patients with other autoimmune diseases.
    Read the publication: Anti–Brush Border Antibody Disease (Anti-LRP2 Nephropathy) Associated With Lupus Nephritis
    12 min

About Arkana Advances

From the publisher's feed

Arkana Advances is a research podcast, hosted by Dr. Rebecca May, discussing the work of Arkana physicians and scientists as they ask questions that lead to advancing the understanding of disease.